The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus

Gershan Mathur; B. Noronha; E. Rodrigues; G. Davis

doi:10.1111/j.1463-1326.2006.00644.x

The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus

Gershan Mathur^*
, B. Noronha
, E. Rodrigues
, G. Davis

^*Corresponding author for this work

Liverpool University Hospitals NHS Foundation Trust
Cardiovascular Research Group

Research output: Contribution to journal › Review article › peer-review

9 Citations (Scopus)

Abstract

Angiotensin II Receptor blockers (ARBs) are an important addition to the current range of medications available for treating a wide spectrum of diseases including cardiovascular diseases. Coronary heart disease (CHD) is the most common cause of death in the United Kingdom and worldwide. More importantly, the presence of the metabolic syndrome and the likelihood of diabetes mellitus taking on epidemic proportions in the years to come all threaten to maintain the mortality rate due to CHD. This review article focuses on the clinical studies that have helped define the trends in the usage of these agents in the prevention and treatment of diabetes mellitus and its complications and also explores possible mechanisms of action and future developments.

Original language	English
Pages (from-to)	617-629
Number of pages	13
Journal	Diabetes, Obesity and Metabolism
Volume	9
Issue number	5
DOIs	https://doi.org/10.1111/j.1463-1326.2006.00644.x
Publication status	Published - 21 Aug 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Angiotensin II receptor blockers
Diabetes mellitus
Microalbuminuria
Renal disease
Rennin angiotensin system

Access to Document

10.1111/j.1463-1326.2006.00644.x

Cite this

@article{d4d614382946464b8fcfbcc5712eff0d,

title = "The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus",

abstract = "Angiotensin II Receptor blockers (ARBs) are an important addition to the current range of medications available for treating a wide spectrum of diseases including cardiovascular diseases. Coronary heart disease (CHD) is the most common cause of death in the United Kingdom and worldwide. More importantly, the presence of the metabolic syndrome and the likelihood of diabetes mellitus taking on epidemic proportions in the years to come all threaten to maintain the mortality rate due to CHD. This review article focuses on the clinical studies that have helped define the trends in the usage of these agents in the prevention and treatment of diabetes mellitus and its complications and also explores possible mechanisms of action and future developments.",

keywords = "Angiotensin II receptor blockers, Diabetes mellitus, Microalbuminuria, Renal disease, Rennin angiotensin system",

author = "Gershan Mathur and B. Noronha and E. Rodrigues and G. Davis",

year = "2006",

month = aug,

day = "21",

doi = "10.1111/j.1463-1326.2006.00644.x",

language = "English",

volume = "9",

pages = "617--629",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus

AU - Mathur, Gershan

AU - Noronha, B.

AU - Rodrigues, E.

AU - Davis, G.

PY - 2006/8/21

Y1 - 2006/8/21

N2 - Angiotensin II Receptor blockers (ARBs) are an important addition to the current range of medications available for treating a wide spectrum of diseases including cardiovascular diseases. Coronary heart disease (CHD) is the most common cause of death in the United Kingdom and worldwide. More importantly, the presence of the metabolic syndrome and the likelihood of diabetes mellitus taking on epidemic proportions in the years to come all threaten to maintain the mortality rate due to CHD. This review article focuses on the clinical studies that have helped define the trends in the usage of these agents in the prevention and treatment of diabetes mellitus and its complications and also explores possible mechanisms of action and future developments.

AB - Angiotensin II Receptor blockers (ARBs) are an important addition to the current range of medications available for treating a wide spectrum of diseases including cardiovascular diseases. Coronary heart disease (CHD) is the most common cause of death in the United Kingdom and worldwide. More importantly, the presence of the metabolic syndrome and the likelihood of diabetes mellitus taking on epidemic proportions in the years to come all threaten to maintain the mortality rate due to CHD. This review article focuses on the clinical studies that have helped define the trends in the usage of these agents in the prevention and treatment of diabetes mellitus and its complications and also explores possible mechanisms of action and future developments.

KW - Angiotensin II receptor blockers

KW - Diabetes mellitus

KW - Microalbuminuria

KW - Renal disease

KW - Rennin angiotensin system

UR - https://www.scopus.com/pages/publications/34547948451

UR - https://www.scopus.com/pages/publications/34547948451#tab=citedBy

U2 - 10.1111/j.1463-1326.2006.00644.x

DO - 10.1111/j.1463-1326.2006.00644.x

M3 - Review article

C2 - 17697055

AN - SCOPUS:34547948451

SN - 1462-8902

VL - 9

SP - 617

EP - 629

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 5

ER -

The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this